$SYBX 3 SEC Filings

Filed On	Filing
21 Mar 2024	Form 3: Dooley Mary Beth, Head of Finance Holds 15,419 shares of Common Stock
21 Mar 2024	Form 3: Flynn James P, Director No securities owned
16 Feb 2024	Form 3: Funicular Funds, Lp, 10% owner and 2 others Holds 3,312,219 shares of Common stock
06 Oct 2023	Form 3: New Enterprise Associates 14, L.p., 10% owner and 6 others Holds 2,922,773 shares of Common Stock
03 Mar 2022	Form 3: Jensen Michael Vangsted, Chief Financial Officer No securities owned
11 Feb 2021	Form 3: Kelly-Croswell Lisa, Director No securities owned
09 Dec 2020	Form 3: Heffernan Michael Thomas, Director No securities owned
10 Aug 2020	Form 3: Awad Antoine, Chief Operating Officer Holds 25,500 shares of Common Stock
04 Feb 2020	Form 3: Burgess Michael F., Director No securities owned
24 Oct 2019	Form 3: Beloff Gregg, See Remarks No securities owned
18 Sep 2019	Form 3: Riese Richard J., Chief Medical Officer No securities owned
21 Jun 2019	Form 3: Ginkgo Bioworks, Inc., 10% owner Holds 6,340,771 shares of Common Stock
07 May 2019	Form 3: Plevy Scott Eric, Chief Scientific Officer No securities owned
12 Feb 2019	Form 3: Hurter Patricia N., Director No securities owned
10 Oct 2017	Form 3: Gengos Andrew, See Remarks No securities owned
30 Aug 2017	Form 3: Leschly Nick, Director Holds 23,150 shares of Common Stock
30 Aug 2017	Form 3: Gutierrez-Ramos Jose-Carlos, Director Holds 362,619 shares of Common Stock
30 Aug 2017	Form 3: Shea Richard P, Director No securities owned
30 Aug 2017	Form 3: Miller Paul Francis, Chief Scientific Officer Holds 41,676 shares of Common Stock
30 Aug 2017	Form 3: Barrett Peter, Director Holds 2,651,963 shares of Common Stock

Comments